My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 210

    1.

    Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.

    Nielsen S, Møller N, Christiansen JS, Jørgensen JO.

    Diabetes. 2001 Oct;50(10):2301-8.PMID: 11574412 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.

    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.

    Eur J Endocrinol. 2003 Dec;149(6):511-9.PMID: 14640991 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.

    Nielsen S, Møller N, Pedersen SB, Christiansen JS, Jørgensen JO.

    J Clin Endocrinol Metab. 2002 Jul;87(7):3274-8.PMID: 12107236 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.

    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.

    J Clin Endocrinol Metab. 2001 Dec;86(12):5813-8.PMID: 11739444 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.

    Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JO.

    Eur J Endocrinol. 2005 Oct;153(4):545-9. Erratum in: Eur J Endocrinol. 2005 Nov;153(5):721. PMID: 16189176 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.

    Nørrelund H, Nielsen S, Christiansen JS, Jørgensen JO, Møller N.

    Eur J Endocrinol. 2004 Jun;150(6):779-87.PMID: 15191347 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.

    Pontiroli AE, Manzoni MF, Malighetti ME, Lanzi R.

    J Clin Endocrinol Metab. 1996 Nov;81(11):3998-4001.PMID: 8923850 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients.

    Alvarez P, Isidro L, Peinó R, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.

    Clin Endocrinol (Oxf). 2003 Oct;59(4):431-6.PMID: 14510904 [PubMed - indexed for MEDLINE]Related articles

    9.

    Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.

    Lanzi R, Luzi L, Caumo A, Andreotti AC, Manzoni MF, Malighetti ME, Sereni LP, Pontiroli AE.

    Metabolism. 1999 Sep;48(9):1152-6.PMID: 10484056 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.

    Nielsen S, Jørgensen JO, Hartmund T, Nørrelund H, Nair KS, Christiansen JS, Møller N.

    Growth Horm IGF Res. 2002 Dec;12(6):425-33.PMID: 12423628 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat.

    Vickers MH, Hofman PL, Gluckman PD, Lobie PE, Cutfield WS.

    Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1212-9. Epub 2006 Jun 27.PMID: 16803850 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.

    Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jørgensen JO.

    Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E920-7. Epub 2006 Nov 28.PMID: 17132823 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.

    Van Dam PS, Smid HE, de Vries WR, Niesink M, Bolscher E, Waasdorp EJ, Dieguez C, Casanueva FF, Koppeschaar HP.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4706-11.PMID: 11134132 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.

    Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, Froesch ER.

    J Clin Invest. 1994 Sep;94(3):1126-33.PMID: 8083353 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans.

    Gormsen LC, Jessen N, Gjedsted J, Gjedde S, Nørrelund H, Lund S, Christiansen JS, Nielsen S, Schmitz O, Møller N.

    J Clin Endocrinol Metab. 2007 May;92(5):1834-42. Epub 2007 Mar 6.PMID: 17341555 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects.

    Jørgensen JO, Møller J, Alberti KG, Schmitz O, Christiansen JS, Orskov H, Moller N.

    J Clin Endocrinol Metab. 1993 Dec;77(6):1589-96.PMID: 8263146 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mediation of the hepatic effects of growth hormone by its lipolytic activity.

    Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, Pontiroli AE.

    J Clin Endocrinol Metab. 1999 May;84(5):1658-63.PMID: 10323396 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The control on growth hormone release by free fatty acids is maintained in acromegaly.

    Lanzi R, Losa M, Mignogna G, Caumo A, Pontiroli AE.

    J Clin Endocrinol Metab. 1999 Apr;84(4):1234-8.PMID: 10199760 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.

    Saloranta C, Groop L, Ekstrand A, Franssila-Kallunki A, Taskinen MR.

    Acta Diabetol. 1994 Apr;31(1):6-13.PMID: 8043900 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects.

    Lanzi R, Manzoni MF, Andreotti AC, Malighetti ME, Bianchi E, Sereni LP, Caumo A, Luzi L, Pontiroli AE.

    J Clin Endocrinol Metab. 1997 Jul;82(7):2239-43.PMID: 9215300 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity